Celiac.com Sponsor (A1):


Join eNewsletter


Celiac.com Sponsor (A1-m):



Join eNewsletter
  • Join Our Community!

    Ask us a question in our celiac / gluten-free forum.

  • Plant Bioscience Ltd

    New Low-gliadin Wheat Acceptable to People with Gluten Sensitivity and also Shows Potential Beneficial Effects on the Gut Microbiome, Compared with a Gluten-free Diet

    Plant Bioscience Ltd
    0
    Reviewed and edited by a celiac disease expert.

      Journal of Gluten Sensitivity Spring 2019 Issue.


    Image: CC--USDA NRCS Montana
    Caption: Image: CC--USDA NRCS Montana

    Celiac.com 02/15/2019 - Aiming for a wheat that is safe for people with coeliac disease and other gluten-sensitive individuals to consume, Professor Francisco Barro and colleagues of the CSIC Institute for Sustainable Agriculture in Cordoba, Spain have developed transgenic wheat lines in which the gliadin proteins (the gluten elements responsible for the damaging immune response of people with coeliac disease) have been strongly, and specifically, supressed.(1)

    Now, a study published in December 2018 in the journal Nutrients(2) has shown that fresh bread, made from the new wheat line, causes no negative response in non-coeliac gluten sensitive (NCGS) individuals when consumed regularly over several days. The bread was considered highly palatable by the trial participants. Moreover, in addition to the success in not triggering any acute gut symptoms, analysis of gut microbial populations demonstrated that the low-gliadin bread caused clear changes in the microbial profile consistent with a more beneficial population of natural bacteria, when compared to the profile present whilst consuming a gluten-free diet.



    Celiac.com Sponsor (A12):






    Celiac.com Sponsor (A12-m):




    The new wheat lines are being developed as an alternative option for people with gluten sensitivity by commercial partners of Plant Bioscience Limited, a UK-based technology transfer company, who have also patented the new wheat lines on behalf of CSIC.

    Prof. Barro said "This wheat opens up exciting new perspectives for NCGS patients; it's like following a gluten-free diet but with the aroma and taste of traditional wheat bread and favouring a much healthier microbiome."

    Professor Alastair Forbes, Clinical Professor in Medicine at the University of East Anglia, a leader in gastroenterology clinical research said; "This work is really encouraging news for the gluten sensitivity research community and the patients it serves. With no apparent drawbacks we now have a promising new wheat line in development that is non-toxic and promotes a healthier gut microbiome than the often-unpalatable gluten-free options hitherto available."

    Sarah Sleet, Coeliac UK chief executive said: "This is an exciting development showing real potential to develop a new bread from wheat, that may be suitable for people with coeliac
    disease. We’re not quite there yet, as this paper shows that bread from LGW is acceptable to people with gluten sensitivity but it has not completed testing in individuals with coeliac
    disease. We look forward to seeing the results of the ongoing tests in coeliac patients, who currently must follow a lifelong strict gluten-free diet to manage this serious autoimmune condition."

    For enquiries regarding the low-gliadin wheat, please contact Plant Bioscience Limited on telephone +44 (0)1603 45600, or via email info@pbltechnology.com.

    The full article can be read for free here: https://www.mdpi.com/2072-6643/10/12/1964 

    References:

    1. Effective shutdown in the expression of celiac disease-related wheat gliadin T-cell epitopes by RNA interference. Gil-Humanes J, Pistón F, Tollefsen S, Sollid LM, Barro F (2010). PNAS; 107(39): 17023-17028.
    2. The Dietary Intervention of Transgenic Low-Gliadin Wheat Bread in Patients with Non-Celiac Gluten Sensitivity (NCGS) Showed No Differences with Gluten Free Diet (GFD) but Provides Better Gut Microbiota Profile. Carmen Haro, Myriam Villatoro, Luis Vaquero, Jorge Pastor , María J. Giménez, Carmen V. Ozuna, Susana Sánchez-León, María D. García-Molina, Verónica Segura, Isabel Comino, Carolina Sousa, Santiago Vivas, Blanca B. Landa and Francisco Barro (2018). Nutrients; 10(12), 1964.
    0

    User Feedback

    Recommended Comments

    On 2/15/2019 at 12:59 PM, Scott Adams said:

    This is relevant news to anyone who has issues with gluten.

    Why is there a push to downplay the dangers of gluten to celiacs. Whisky? Drink it. Gluten reduced flour? Eat it, or you are overreacting. Its not ok, and potentially a dangerous thing to promote.

    Share this comment


    Link to comment
    Share on other sites


    Join the conversation

    You are posting as a guest. If you have an account, sign in now to post with your account.
    Note: Your post will require moderator approval before it will be visible.

    Guest
    Add a comment...

    ×   Pasted as rich text.   Restore formatting

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


  • About Me

    Plant Bioscience Ltd (PBL, Norwich, UK) - an independent technology management company
    specialising in plant, food and microbial science.


  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-m):




  • Related Articles

    Jefferson Adams
    Celiac.com 02/24/2017 - Have wheat and gluten changed over time? Is the wheat we consume today substantially different to the wheat we ate fifty or one-hundred years ago? These are interesting questions that have invited a good deal of speculation, but so far, at least, no good answers.
    Dr. Chris Miller, a former faculty member at Kansas State University in Grain Science and Industry, now the director of wheat quality research at Heartland Plant Innovations, is working on a project that could allow people with celiac disease to safely consume wheat. As part of that project, Dr. Miller is studying different wheat varieties from the Kansas State University...

    Jefferson Adams
    Celiac.com 03/22/2017 - A new study published in the journal Food Chemistry shows that even the ancient varieties of wheat that have not been subject to hybridization, contain toxic epitopes that trigger adverse autoimmune response in celiac patients.
    What makes gluten toxic to people with celiac disease? Also, what is the relationship between various kinds of wheat and their celiac toxicity?
    To answer those questions, a team of researchers analyzed various kinds of wheat from several countries, all produced in the same agronomic year (2013-2014) at the Experimental Station at the Agronomic, Food and Biosystems School of Madrid.
    Their study...

    Jefferson Adams
    Celiac.com 10/25/2017 - For people with celiac disease, eating gluten proteins from wheat, barley, and rye triggers an auto-immune response, and the accompanying physical symptoms.
    A team of researchers recently set out to engineer low-gluten wheat strains that also have low-reactivity for people with celiac disease. To meet their goals, the team designed two sgRNAs to target a conserved region adjacent to the coding sequence for the 33-mer in the -gliadin genes. They then sought to evaluate the results.
    The research team included Susana Sánchez-León, Javier Gil-Humanes, Carmen V. Ozuna, María J. Giménez, Carolina Sousa, Daniel F. Voytas, and Fra...

    Jefferson Adams
    Celiac.com 02/11/2019 - Researchers have shown that CRISPR-Cas9 gene-editing technology can be used to remove epitopes from gliadin protein in gluten. These molecules trigger the adverse immune response seen in people with celiac disease. However, will Europe’s strict GM rules prevent this discovery from being used to create new gluten-free products for people with celiac disease?
    Researchers at Wageningen University in the Netherlands, and at the National Institute of Agricultural Botany (NIAB) in the UK, have shown that CRISPR-Cas9 gene-editing technology can be used to remove epitopes from gliadin protein in gluten. Gluten contains an assortment g...